The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CONNECT BIOPHARMA HLDGS LTD | SHS | G23549101 | 1,913,925 | 1,267,500 | SH | SOLE | 0 | 0 | 1,267,500 | |||
| MURAL ONCOLOGY PUB LTD CO | ORD SHS | G63365103 | 119,025 | 57,500 | SH | SOLE | 0 | 0 | 57,500 | |||
| LAVA THERAPEUTICS NV | SHS | N51517105 | 3,074,152 | 1,970,610 | SH | SOLE | 0 | 0 | 1,970,610 | |||
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | 27,075,000 | 14,250,000 | SH | SOLE | 0 | 0 | 14,250,000 | |||
| ADVERUM BIOTECHNOLOGIES INC | COM NEW | 00773U207 | 13,850,593 | 3,057,526 | SH | SOLE | 0 | 0 | 3,057,526 | |||
| ALUMIS INC | COM | 022307102 | 4,829,556 | 1,210,415 | SH | SOLE | 0 | 0 | 1,210,415 | |||
| ARVINAS INC | COM | 04335A105 | 426,000 | 50,000 | SH | SOLE | 0 | 0 | 50,000 | |||
| ASTROTECH CORP | COM | 046484309 | 1,080,009 | 220,410 | SH | SOLE | 0 | 0 | 220,410 | |||
| ATEA PHARMACEUTICALS INC | COM | 04683R106 | 21,674,493 | 7,473,963 | SH | SOLE | 0 | 0 | 7,473,963 | |||
| ATHIRA PHARMA INC | COM | 04746L203 | 1,337,493 | 323,066 | SH | SOLE | 0 | 0 | 323,066 | |||
| LISATA THERAPEUTICS INC | COM | 128058302 | 287,783 | 109,841 | SH | SOLE | 0 | 0 | 109,841 | |||
| IMAGENEBIO INC | COM | 45175G207 | 1,487,448 | 182,509 | SH | SOLE | 0 | 0 | 182,509 | |||
| INSTIL BIO INC | COM NEW | 45783C200 | 11,530,416 | 645,600 | SH | SOLE | 0 | 0 | 645,600 | |||
| KEZAR LIFE SCIENCES INC | COM NEW | 49372L209 | 2,811,069 | 720,787 | SH | SOLE | 0 | 0 | 720,787 | |||
| ORAMED PHARMACEUTICALS INC | COM NEW | 68403P203 | 8,361,490 | 3,167,231 | SH | SOLE | 0 | 0 | 3,167,231 | |||
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | 7,408,800 | 5,292,000 | SH | SOLE | 0 | 0 | 5,292,000 | |||
| TARGET CORP | COM | 87612E106 | 897,000 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | |||
| THIRD HARMONIC BIO INC | COM | 88427A107 | 0 | 3,824,417 | SH | SOLE | 0 | 0 | 3,824,417 | |||
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | 532,500 | 150,000 | SH | SOLE | 0 | 0 | 150,000 | |||
| WALMART INC | COM | 931142103 | 518,738 | 265 | SH | Put | SOLE | 0 | 0 | 265 | ||